LIPIDLAR VA YURAK-QON TOMIR KASALLIKLARI
Keywords:
Lipidlar, lipoproteinlar, dislipidemiya, ateroskleroz, yurak-qon tomir kasalliklari, xolesterin, LDL (past zichlikdagi lipoproteinlar), HDL (yuqori zichlikdagi lipoproteinlar), triglitseridlar, yog‘ almashinuvi, metabolizm, giperlipidemiya, gipoxolesterinemiya, qon tomir patologiyasi, miokard infarkti, insult, endotelial disfunktsiya, oksidlovchi stress, yallig‘lanish jarayoni, semizlik, diabet mellitus, arterial gipertenziya, sog‘lom turmush tarzi, profilaktika, dietoterapiya, statinlar, farmakoterapiya, biologik faol moddalar, yurak salomatligi.Abstract
Mazkur maqolada lipidlarning kimyoviy tuzilishi, biologik funksiyalari hamda ularning inson organizmidagi metabolik jarayonlardagi o‘rni kompleks tarzda yoritilgan. Ayniqsa, lipidlar almashinuvining buzilishi natijasida yuzaga keladigan dislipidemiya holati va uning yurak-qon tomir tizimi patologiyalarini rivojlantirishdagi roli ilmiy asosda tahlil qilingan. Qonda past zichlikdagi lipoproteinlar (LDL), yuqori zichlikdagi lipoproteinlar (HDL) va triglitseridlar darajasining o‘zgarishi natijasida yuzaga keladigan patofiziologik jarayonlar, xususan, ateroskleroz rivojlanish mexanizmlari batafsil bayon etilgan. Maqolada aterosklerotik jarayonning bosqichlari, ya’ni endotelial disfunktsiya, lipidlarning oksidlanishi, makrofaglar tomonidan yutilishi va “ko‘pik hujayralar” (foam cells) hosil bo‘lishi kabi muhim bosqichlar ilmiy nuqtai nazardan tushuntiriladi. Shuningdek, yurak-qon tomir kasalliklarining asosiy klinik ko‘rinishlari — miokard infarkti, insult va arterial gipertenziya bilan o‘zaro bog‘liqligi ham ochib berilgan. Bundan tashqari, maqolada yurak-qon tomir kasalliklarining rivojlanishiga ta’sir etuvchi asosiy xavf omillari, jumladan, noto‘g‘ri ovqatlanish, gipodinamiya, semizlik, diabet mellitus va zararli odatlarning lipid profiliga salbiy ta’siri yoritilgan. Profilaktika masalalariga alohida e’tibor qaratilib, sog‘lom turmush tarzini shakllantirish, ratsional ovqatlanish, jismoniy faollikni oshirish hamda zamonaviy farmakoterapiya, xususan, statinlar qo‘llashning ahamiyati asoslab berilgan. Mazkur tadqiqot natijalari lipidlar almashinuvini nazorat qilish orqali yurak-qon tomir kasalliklarining oldini olish va ularni samarali boshqarish imkoniyatlarini kengaytirishga xizmat qiladi.
References
Guyton and Hall. Textbook of Medical Physiology. Elsevier, 2021.
David L. Nelson, Michael M. Cox. Lehninger Principles of Biochemistry. W.H. Freeman, 2021.
Harper. Harper’s Illustrated Biochemistry. McGraw-Hill, 2022.
World Health Organization. Cardiovascular Diseases (CVDs) Report. Geneva, 2023.
American Heart Association. Heart Disease and Stroke Statistics. 2023.
European Society of Cardiology. Guidelines on Cardiovascular Disease Prevention. 2021.
National Institutes of Health. Cholesterol Treatment Guidelines. 2022.
Robbins and Cotran Pathologic Basis of Disease. Elsevier, 2021.
Centers for Disease Control and Prevention. Heart Disease Facts. 2023.
The Lancet. “Global Burden of Cardiovascular Diseases”, 2022.
Journal of the American College of Cardiology. Lipid metabolism studies, 2021–2023.
Circulation. Cardiovascular risk and lipid profile research, 2022.
Uzbekiston Respublikasi Sog‘liqni saqlash vazirligi. Yurak-qon tomir kasalliklari bo‘yicha milliy qo‘llanma, 2022.
Marks' Basic Medical Biochemistry. Wolters Kluwer, 2020.





